a $650B industry in Covid’s wake

 
China's digital currency. 
#2 e-commerce platform. A P&C crisis. 
VIEW IN BROWSER
CBINSIGHTS July 9, 2020
Insurance gets a tech boost

Hola,

This week, we take a look at why tech has not been front and center in insurance, how the Covid-19 pandemic may change that, and the tailwinds and headwinds that will impact insurtech categories.

 

We look at: 

Read more about it here.
THE RESEARCH
Defense against the dark (web) arts

Corporates are increasingly under pressure to fend off cyber attacks. 

From disinformation detection to decentralized digital identities, we take a look at emerging cybersecurity trends and startups in our new Cyber Defenders report here.

Can’t pump this
 

Didi Chuxing is testing China's new digital currency in a pilot program.

 

We cover how governments are ramping up involvement with digital currencies in our 53-page Blockchain Report

We’re all in this together
 

The worst is yet to come for P&C insurers, as businesses begin to shutter permanently and cut off major revenue streams. 

 

We dive into why the P&C industry has remained stagnant for so long and how insurtech can help firms move forward in this report.

Shop 'til you drop
 

In 2019, Shopify powered the most e-commerce sales in the US after Amazon.


Clients can read our teardown of how this e-commerce platform for SMBs is continuing to expand its footprint here.

CORE INTELLIGENCE
Trend Of The Week

From telehealth platforms to remote monitoring and care delivery, digital health has been a  bright spot for investment throughout the pandemic.

 

This week, we’re featuring our graphic of the most active digital health investors in Europe.

Source: CB Insights

While the US still claims the majority of digital health deals, Europe has gained traction in recent years, with Europe-based digital health startups raising a record $2.6B across 312 deals in 2019.

Since publishing our graphic, Bpifrance, the top investor in our graphic, has made another digital health investment, participating in France-based Synapse Medicine’s Series A round on Monday. Synapse develops a medication intelligence platform and virtual assistant for healthcare professionals.

For more on global healthcare investment amid Covid-19, take a look at our Q2’20 healthcare research resource page.

Have a great weekend.



Marcelo
@ballve

P.S. If you want to see the insurtech material live, sign up for our webinar.
 

P.P.S. We're looking for a senior full stack engineer. Check out the job specs here

Get started with CB Insights.
START YOUR FREE TRIAL
CB Insights' emerging technology insights platform
provides all the analysis and data from this newsletter.
Our data is the easiest way to discover and respond
to emerging tech. Access it here. 
SEND TO A FRIEND
tw in mailto
CBIINSIGHTS
Copyright © 2020 CB Information Services, All rights reserved.
498 7th ave, 12th floor, New York, NY 10018
About Us | Unsubscribe | Update Preferences | Research | Newsletter

a $650B industry in Covid’s wake